Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John I Manchester

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Future Medicinal Chemistry|July 18, 2013
A fresh start in the hunt for novel antibacterialsJohn I Manchester
Methods in Molecular Biology (Clifton, N.J.)|October 3, 2002
Designing combinatorial libraries for efficient screeningJohn I Manchester, David S Hartsough
ACS Infectious Diseases|September 14, 2016
A New-Class Antibacterial-Almost. Lessons in Drug Discovery and Development: A Critical Analysis of More than 50 Years of Effort toward ATPase Inhibitors of DNA Gyrase and Topoisomerase IVGregory S Bisacchi, John I Manchester
Journal of Medicinal Chemistry|January 10, 2012
Molecular determinants of AcrB-mediated bacterial efflux implications for drug discoveryJohn I Manchester, Ed T Buurman, Gregory S Bisacchi, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Antimicrobial Activity of Adenine-Based Inhibitors of NAD(+)-Dependent DNA LigaseEd T Buurman, Valerie A Laganas, Ce Feng Liu, et al.
Nature Reviews. Drug Discovery|July 4, 2015
ESKAPEing the labyrinth of antibacterial discoveryRuben Tommasi, Dean G Brown, Grant K Walkup, et al.
Archives of Biochemistry and Biophysics|February 8, 2002
Active site mutations of cytochrome p450cam alter the binding, coupling, and oxidation of the foreign substrates (R)- and (s)-2-ethylhexanolKevin J French, Dan A Rock, Denise A Rock, et al.
International Journal of Antimicrobial Agents|January 12, 2013
Novel topoisomerase inhibitors: microbiological characterisation and in vivo efficacy of pyrimidinesMaria Uria-Nickelsen, Georg Neckermann, Shubha Sriram, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2012
Discovery of a novel azaindole class of antibacterial agents targeting the ATPase domains of DNA gyrase and Topoisomerase IVJohn I Manchester, Daemian D Dussault, Jonathan A Rose, et al.
Journal of Medicinal Chemistry|October 9, 2013
Fragment-to-hit-to-lead discovery of a novel pyridylurea scaffold of ATP competitive dual targeting type II topoisomerase inhibiting antibacterial agentsGregory S Basarab, John I Manchester, Shanta Bist, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Future Medicinal Chemistry|July 18, 2013
A fresh start in the hunt for novel antibacterialsJohn I Manchester
Methods in Molecular Biology (Clifton, N.J.)|October 3, 2002
Designing combinatorial libraries for efficient screeningJohn I Manchester, David S Hartsough
ACS Infectious Diseases|September 14, 2016
A New-Class Antibacterial-Almost. Lessons in Drug Discovery and Development: A Critical Analysis of More than 50 Years of Effort toward ATPase Inhibitors of DNA Gyrase and Topoisomerase IVGregory S Bisacchi, John I Manchester
Journal of Medicinal Chemistry|January 10, 2012
Molecular determinants of AcrB-mediated bacterial efflux implications for drug discoveryJohn I Manchester, Ed T Buurman, Gregory S Bisacchi, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Antimicrobial Activity of Adenine-Based Inhibitors of NAD(+)-Dependent DNA LigaseEd T Buurman, Valerie A Laganas, Ce Feng Liu, et al.
Nature Reviews. Drug Discovery|July 4, 2015
ESKAPEing the labyrinth of antibacterial discoveryRuben Tommasi, Dean G Brown, Grant K Walkup, et al.
Archives of Biochemistry and Biophysics|February 8, 2002
Active site mutations of cytochrome p450cam alter the binding, coupling, and oxidation of the foreign substrates (R)- and (s)-2-ethylhexanolKevin J French, Dan A Rock, Denise A Rock, et al.
International Journal of Antimicrobial Agents|January 12, 2013
Novel topoisomerase inhibitors: microbiological characterisation and in vivo efficacy of pyrimidinesMaria Uria-Nickelsen, Georg Neckermann, Shubha Sriram, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2012
Discovery of a novel azaindole class of antibacterial agents targeting the ATPase domains of DNA gyrase and Topoisomerase IVJohn I Manchester, Daemian D Dussault, Jonathan A Rose, et al.
Journal of Medicinal Chemistry|October 9, 2013
Fragment-to-hit-to-lead discovery of a novel pyridylurea scaffold of ATP competitive dual targeting type II topoisomerase inhibiting antibacterial agentsGregory S Basarab, John I Manchester, Shanta Bist, et al.
Pageof 2